Peptide record

TPDB64091

Blood-Brain Barrier Cell-penetrating Peptides Tumor-homing Peptides modified_plain modified
4 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB64091
Blood-Brain Barrier Cell-penetrating Peptides Tumor-homing Peptides
Cancer-related peptides Delivery and barrier-penetrating peptides
Peptipedia CPPsite3.0 TumorHoPe2.0
modified_plain
Yes
A 4-aa modified multi-activity (Blood-Brain Barrier, Cell-penetrating Peptides, and Tumor-homing Peptides) peptide sequence curated from Peptipedia, CPPsite3.0, and TumorHoPe2.0, with an available 3D structural model.
C-terminal: Biotin N-terminal: Fluorescein isothiocyanate (FITC)
Sequence
SIWV
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
4 reviewed residue count
Biotin Activity
Fluorescein isothiocyanate (FITC) Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Tumor-homing Peptides

Target

Homing, Penetrating
Brain tumor

Source & Reference

TumorHoPe2.0
TumorHoPe2
A brain tumor-homing tetra-peptide delivers a nano-therapeutic for more effective treatment of a mouse model of glioblastoma
2020
Kang R H et al. Nanoscale Horiz.2020 Jul 27 5(8):1213-1225
Patent pending

Other

Source Activity Label Source Definition
Tumor-homing Peptides
TumorHoPe2.0 experimentally validated tumor-homing peptide annotation.
Human-derived brain carcinoma cells (U87MG cells), lung carcinoma cells (A549 cells), liver carcinoma cells (Huh7 cells)
5- or 6-week-old female BALB/c nu/nu mice, 7-week-old ICR mice
A33H
Fluorescein isothiocyanate (FITC)
Cell penetrating peptide
Additional Detail Fields 3 fields
Fluorescein isothiocyanate (FITC)
Human-derived brain carcinoma cells (U87MG cells), lung carcinoma cells (A549 cells), liver carcinoma cells (Huh7 cells)
5- or 6-week-old female BALB/c nu/nu mice, 7-week-old ICR mice